Thrombotic thrombocytopenic purpura surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombotic thrombocytopenic purpura}} | |||
{{CMG}}; {{AE}} {{S.G.}} | {{CMG}}; {{AE}} {{S.G.}} | ||
Latest revision as of 17:15, 25 February 2019
|
Thrombotic thrombocytopenic purpura Microchapters |
|
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Thrombotic thrombocytopenic purpura surgery On the Web |
|
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura surgery |
|
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
|
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
The mainstay of treatment for TTP is medical therapy. Surgery is usually reserved for patients with either no cure with plasma treatments and medicines.
Indications
- Surgery is not the first line treatment option for patients withTTP when plasma treatments(PEX) and medicines do not cure TTP, surgery is needed.[1]
Surgery
- Surgery is not the first-line treatment option for patients withTTP. Sometimes splenectomy is needed, because the antibodies is made by cell in spleen that block ADAMTS13 enzyme activity.[1]